Loading company…
MetaCenTherapeutics develops drugs for metabolic diseases and manufactures medical food.
MetaCenTherapeutics develops pharmaceutical, medical food and skincare products. Its drug work includes products designed to decompose and discharge sugar toxins. Founded in 2015, the company is based in Suwon, South Korea. It raised KRW 6.2 billion in Series B funding in April 2021.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in